96 related articles for article (PubMed ID: 11412527)
1. [Model of mortality risk in stage I non-small cell bronchogenic carcinoma].
Padilla J; Peñalver J; Calvo V; García Zarza A; Pastor J; Blasco E; París F
Arch Bronconeumol; 2001 Jun; 37(6):287-91. PubMed ID: 11412527
[TBL] [Abstract][Full Text] [Related]
2. Survival and risk model for stage IB non-small cell lung cancer.
Padilla J; Calvo V; Peñalver JC; Zarza AG; Pastor J; Blasco E; París F
Lung Cancer; 2002 Apr; 36(1):43-8. PubMed ID: 11891032
[TBL] [Abstract][Full Text] [Related]
3. [Non-small cell bronchogenic carcinoma in advanced stages: prognostic value of weight loss and clinical implications].
Gullón J; Fernández R; Rubinos G; Medina A; Suárez I; González I
Arch Bronconeumol; 2001 Dec; 37(11):477-81. PubMed ID: 11734136
[TBL] [Abstract][Full Text] [Related]
4. [Postoperative survival in stage II non-small-cell bronchogenic carcinoma].
Calvo Medina V; Padilla Alarcón J; París Romeu F; Blasco Armengod E; Pastor Guillem J; García Zarza A
Arch Bronconeumol; 2001 Jan; 37(1):19-26. PubMed ID: 11181226
[TBL] [Abstract][Full Text] [Related]
5. [Resected non-small cell bronchogenic carcinoma stage pIIIA-N2. Which patients will benefit most from adjuvant therapy?].
Gómez AM; Jarabo JR; Fernandez C; Calatayud J; Fernández E; Torres AJ; Balibrea JL; Hernando F;
Cir Esp; 2014 Apr; 92(4):277-82. PubMed ID: 23453425
[TBL] [Abstract][Full Text] [Related]
6. [Small-cell nonanaplastic bronchogenic carcinoma. The new stage I].
Padilla J; Peñalver JC; Calvo V; García Zarza A; Pastor J; Blasco E; París F
Arch Bronconeumol; 2000 Feb; 36(2):68-72. PubMed ID: 10726193
[TBL] [Abstract][Full Text] [Related]
7. [T2N1M0 non-small cell lung cancer: surgery and prognostic factors].
Padilla J; Calvo V; Peñalver JC; Jordá C; Escrivá J; Cerón J; García Zarza A; Pastor J; Blasco E
Arch Bronconeumol; 2005 Aug; 41(8):430-3. PubMed ID: 16117948
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
[TBL] [Abstract][Full Text] [Related]
9. Sleeve lobectomy for bronchogenic cancers: factors affecting survival.
Fadel E; Yildizeli B; Chapelier AR; Dicenta I; Mussot S; Dartevelle PG
Ann Thorac Surg; 2002 Sep; 74(3):851-8; discussion 858-9. PubMed ID: 12238850
[TBL] [Abstract][Full Text] [Related]
10. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
11. [The prognosis following surgical resection of small-cell nonanaplastic bronchogenic carcinoma according to the new staging guideline: an analysis of 1433 patients].
Padilla J; Calvo V; García Zarza A; Pastor J; Blasco E; París F
Arch Bronconeumol; 1999 Nov; 35(10):483-7. PubMed ID: 10618748
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
13. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
14. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma.
Aragoneses FG; Moreno N; Leon P; Fontan EG; Folque E;
Lung Cancer; 2002 Apr; 36(1):59-63. PubMed ID: 11891034
[TBL] [Abstract][Full Text] [Related]
15. [The radiotherapy of inoperable non-small-cell bronchial carcinoma. A retrospective analysis of 427 cases].
Würschmidt F; Bünemann H; Bünemann C; Beck-Bornholdt HP; Heilmann HP
Strahlenther Onkol; 1994 May; 170(5):302-4. PubMed ID: 8197553
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti CA; Bevilacqua G
J Natl Cancer Inst; 1997 Jun; 89(12):881-6. PubMed ID: 9196255
[TBL] [Abstract][Full Text] [Related]
17. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
18. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control.
Wu YC; Lin CF; Hsu WH; Huang BS; Huang MH; Wang LS
Eur J Cardiothorac Surg; 2003 Dec; 24(6):994-1001. PubMed ID: 14643819
[TBL] [Abstract][Full Text] [Related]
20. [The surgery of non-small-cell bronchogenic carcinoma in stage IIIA. An analysis of 150 treated cases].
Briccoli A; Gelmini R; Spallanzani A; Guernelli N
Minerva Chir; 1999 Apr; 54(4):219-23. PubMed ID: 10380519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
